Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02786147 · ClinicalTrials.gov registry record
Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
A clinical trial, sponsored by Emory University.
- Completed
- Registry status
- 665
- Enrollment target
NCT02786147 is a clinical trial that has completed, run by Emory University. The registered enrollment target is 665 participants.
The verdict
NCT02786147 has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- 665 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the most effective means of follow-up for women who screen positive on B-RST (Breast Cancer Genetics Referral Screening Tool) applied in the standard clinical setting of mammography, to maximize the number who are referred to and receive cancer genetic counseling services. The clinical utility of B-RST 3.0 will also be evaluated by determining the number seen who are appropriate for genetic testing, undergo genetic testing and are found to carry a hereditary cancer gene mutations with medical management implications for the patient and family. The long-term goal is to reduce the morbidity and mortality associated with hereditary causes of breast and ovarian cancer among patients seen in the Emory/Winship system.
Interventions
- OTHER Breast Cancer Genetics Referral Screening Tool 3.0
- OTHER Standard Handout
- OTHER Physician Notification
- OTHER Automatic Follow-Up by Genetic Counseling Staff
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 665 participants |
| Start Date | 2016-04 |
| Est. Completion | 2018-02-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02786147
The ClinicalTrials.gov registry entry for NCT02786147 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 665 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Breast Cancer Genetics Referral Screening Tool 3.0 is the first listed.
NCT02786147 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02786147 about?
NCT02786147 is a clinical study titled "Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer". The purpose of this study is to identify the most effective means of follow-up for women who screen positive on B-RST (Breast Cancer Genetics Referral Screening Tool) applied in the standard clinical setting of mammography, to maximize the number who are referred to and receive cancer genetic counse...
What is the current status of trial NCT02786147?
This trial is currently completed. The enrollment target is 665 participants. The study started on 2016-04. Estimated completion is 2018-02-28.
What interventions are being tested in trial NCT02786147?
The interventions under investigation include: Breast Cancer Genetics Referral Screening Tool 3.0 (OTHER), Standard Handout (OTHER), Physician Notification (OTHER), Automatic Follow-Up by Genetic Counseling Staff (OTHER).
Who is sponsoring clinical trial NCT02786147?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.